The outcomes of transcatheter aortic valve replacement in a cohort of patients with end-stage renal disease

Catheterization and Cardiovascular Interventions

Volumn 87, Issue 7, 2016, Pages 1314-1321

  Szerlip, Molly ^a   Kim, Rebeca J ^b   Adeniyi, Tokunbo ^b   Thourani, Vinod ^c   Babaliaros, Vasilis ^c   Bavaria, Joseph ^d   Herrmann, Howard C ^d   Anwaruddin, Saif ^d   Makkar, Raj ^e   Chakravarty, Tarun ^e   Rovin, Joshua ^f   Creighton, Don ^g   Miller, D Craig ^h   Baio, Kim ^c   Walsh, Elizabeth ^d   Katinic, Jasmina ^f   Letterer, Rebecca ^g   Trautman, Leigh ^h   Herbert, Morley ⁱ   Farkas, Robert ⁱ   Rudolph, Jill ^b   Brown, David ^a   Holper, Elizabeth M ^b   Mack, Michael ^a   more..

^a THE HEART HOSPITAL BAYLOR PLANO   (United States)

^b Cardiopulmonary Research Science and Technology Institute   (United States)

^c EMORY UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

^f Morton Plant Hospital   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ MEDICAL CITY DALLAS HOSPITAL   (United States)

Author keywords

ESRD; Outcomes; TAVR

Indexed keywords

AGED; AORTA STENOSIS; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; END STAGE RENAL DISEASE; FEMALE; HEALTH CARE FACILITY; HEMODIALYSIS; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MALE; MULTICENTER STUDY; PERITONEAL DIALYSIS; RETROSPECTIVE STUDY; SURGICAL MORTALITY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSFEMORAL TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84975106014     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.26347     Document Type: Article

References (27)

1. Sarnak MJ. Cardiovascular complications in chronic kidney disease. American Journal of Kidney Diseases 2003;41:11–17.
2. London GM, Pannier B, Marchais SJ, Guerin AP. Calcification of the aortic valve in the dialyzed patient. J Am Soc Nephrol 2000;11:778–83.
3. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996;27:394–401.
4. Urena P, Malergue MC, Goldfarb B, Prieur P, Guedon-Rapoud C, Petrover M. Evolutive aortic stenosis in hemodialysis patients: Analysis of risk factors. Nephrologie 1999;20:217–25.
5. Baglin A, Hanslik T, Vaillant JN, Boulard JC, Moulonguet-Doleris L, Prinseau J. Severe valvular heart disease in patients on chronic dialysis. A five-year multicenter French survey. Ann Med Interne (Paris) 1997;148:521–6.
6. Umana E, Ahmed W, Alpert MA. Valvular and perivalvular abnormalities in end-stage renal disease. Am J Med Sci 2003;325:237–42.
7. Edwards FH, Peterson ED, Coombs LP, DeLong ER, Jamieson WR, Shroyer ALW, Grover FL. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 2001;37:885–92.
8. Herzog CA. Long-term survival of dialysis patients in the United States with prosthetic heart valves: Should ACC/AHA practice guidelines on valve selection be modified? Circulation 2002;105:1336–1341.
9. Thourani VH, Chowdhury R, Gunter RL, Kilgo PD, Chen EP, Puskas JD, Halkos ME, Lattouf OM, Cooper WA, Guyton RA. The impact of specific preoperative organ dysfunction in patients undergoing aortic valve replacement. Ann Thorac Surg 2013;95:838–45.
10. Kaplon RJ, Cosgrove DM, 3rd Gillinov AM, Lytle BW, Blackstone EH Smedira NG. Cardiac valve replacement in patients on dialysis: Influence of prosthesis on survival. Ann Thorac Surg 2000;70:438–41.
11. Brinkman WT, Williams WH, Guyton RA, Jones EL, Craver JM. Valve replacement in patients on chronic renal dialysis: Implications for valve prosthesis selection. Ann Thorac Surg 2002;74:37–42; discussion 42.
12. Lucke JC, Samy RN, Atkins BZ, Silvestry SC, Douglas JM, Jr., Schwab SJ, Wolfe WG, Glower DD. Results of valve replacement with mechanical and biological prostheses in chronic renal dialysis patients. Ann Thorac Surg 1997;64:129–32. discussion 132-3.
13. Horst M, Mehlhorn U, Hoerstrup SP, Suedkamp M, de Vivie ER. Cardiac surgery in patients with end-stage renal disease: 10-year experience. Ann Thorac Surg 2000;69:96–101.
14. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP Makkar RR., others. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597–607.
15. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187–98.
16. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014;370:1790–8.
17. Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, Hermiller J, Jr., Hughes GC, Harrison JK, Coselli J, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 2014;63:1972–81.
18. Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip D, Evan Es GA, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012;60:1438–54.
19. Surgeons TSoT.Adult Cardiac Surgery Database Training Manual, v2.73. The Society of Thoracic Surgeons.
20. U.S. Renal Data System: USRDS 2014 Annual Data Report.
21. Thourani VH, Keeling WB, Sarin EL, Guyton RA, Kilgo PD, Dara AB, Puskas JD, Chen EP, Cooper WA Vega JD., others. Impact of preoperative renal dysfunction on long-term survival for patients undergoing aortic valve replacement. Ann Thorac Surg 2011;91:1798–806. discussion 1806-7.
22. Lerakis S, Hayek SS, Douglas PS. Paravalvular aortic leak after transcatheter aortic valve replacement: Current knowledge. Circulation 2013;127:397–407.
23. Rau S, Wessely M, Lange P, Kupatt C, Steinbeck G, Fischereder M, Schonermarck U. Transcatheter aortic valve implantation in dialysis patients. Nephron Clin Pract 2012;120:c86–90.
24. Dumonteil N, van der Boon RM, Tchetche D, Chieffo A, Van Mieghem NM, Marcheix B, Buchanan GL, Vahdat O, Serruys PW Fajadet J., others. Impact of preoperative chronic kidney disease on short- and long-term outcomes after transcatheter aortic valve implantation: A Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC-Plus) initiative substudy. Am Heart J 2013;165:752–60.
25. Ferrari E, Namasivayam J, Marcucci C, Gronchi F, Berdajs D, Niclauss L, von Segesser LK. Transapical aortic valve replacement in extreme-risk patients: Outcome, risk factors and mid-term results. Eur J Cardiothorac Surg 2013;43:978–85.
26. Mack MJ, Brennan JM, Brindis R, Carroll J, Edwards F, Grover F, Shahian D, Tuzcu EM, Peterson ED, Rumsfeld JS, et al. Outcomes following transcatheter aortic valve replacement in the United States. Jama 2013;310:2069–77.
27. Edgerton JR, Herbert MA, Mahoney C, Armstrong D, Dewey TM, Holper E, Roper K, Mack MJ. Long-term fate of patients discharged to extended care facilities after cardiovascular surgery. Ann Thorac Surg 2013;96:871–7.